SANGAMO THERAPEUTICS, INC. Stock Split Ratio
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Stock Split Ratio of 133.00% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2019-03-01
- SANGAMO THERAPEUTICS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2018 was 133.00%, a 0.00% change from fiscal 2017.
- SANGAMO THERAPEUTICS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2017 was 133.00%, a 0.00% change from fiscal 2016.
- SANGAMO THERAPEUTICS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2016 was 133.00%, a 0.00% change from fiscal 2015.
- SANGAMO THERAPEUTICS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2015 was 133.00%, a 0.00% change from fiscal 2014.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|
| 2018-12-31 | 133.00% 10-K · filed 2019-03-01 |
| 2017-12-31 | 133.00% 10-K · filed 2018-03-01 |
| 2016-12-31 | 133.00% 10-K · filed 2017-02-28 |
| 2015-12-31 | 133.00% 10-K · filed 2016-02-18 |
| 2014-12-31 | 133.00% 10-K · filed 2015-02-25 |